Jacob Zuma addresses increased access to antiretrovirals, reduction in HIV incidence

NewsGuard 100/100 Score

South African President Jacob Zuma on Wednesday said he wants to have 80 percent of HIV-positive South Africans who need antiretrovirals (ARVs) on them by 2011, BuaNews reports (BuaNews/allAfrica.com, 6/3).

The announcement was part of Zuma's first state-of-the-nation address, when he discussed ways the government would strive to "step up measures to improve health care in Africa's strongest economy," Reuters writes. "We have set ourselves the goals of reducing inequalities in health care ... and step up the fight against the scourge of HIV and AIDS, TB and other diseases," Zuma said (Roelf, Reuters, 6/4).

"Over 630,000 people are on [the] government's [ARV] programme currently," BuaNews/allAfrica.com writes, and provisions are in place to increase that number to 1.4 million by 2011 or 2012. During his address Zuma also discussed the need for the government to collaborate with stakeholders on a comprehensive plan "which aims to reduce the rate of new HIV infections by 50 percent by the year 2011," BuaNews writes (BuaNews, 6/3).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk